Talking with your healthcare provider
Important Safety Information/
Indications
> LEXIVA® (fosamprenavir calcium)
> EPZICOM® (abacavir sulfate and lamivudine)
> COMBIVIR® (lamivudine/zidovudine)
> TRIZIVIR® (abacavir sulfate, lamivudine, and zidovudine)
> ZIAGEN® (abacavir sulfate)
> EPIVIR® (lamivudine)
> RETROVIR® (zidovudine)
Site map
Site map
- TreatHIV homepage
- HIV medications
- Entry Inhibitors
- Nucleoside Reverse Transcriptase Inhibitors or "Nucs"
- Non-Nucleoside Reverse Transcriptase Inhibitors or "Non-nucs"
- Integrase Inhibitors
- Protease Inhibitors or PIs
- Stay on track
- The importance of adherence
- What is resistance?
- Monitoring treatment
- Side effects
- Switching treatment
- GSK for You
- Talking with your healthcare provider
- GSK's commitment
- HIV resources
- Important Safety Information/Indications